Engineering Better Ageing Market

Engineering Better Ageing Market Overview

The global Engineering Better Ageing Market size was valued at USD XXX billion in 2024 and is predicted to reach USD XXX billion by 2030 with a CAGR of XX% from 2025 to 2030. 

The engineering better ageing market is driven by several factors that includes rise in ageing population with high prevalence of age-related disease along with advancement in regenerative medicine. However, the market growth is hindered due to the risk related from aging treatments. On the other hand, the integration of omics data into the diagnostic tools and medical devices is anticipated to expand the market growth. The key players of the market are investing in research and development to introduce advanced innovative better ageing solutions to propel the market growth. 

Surge in Ageing Population Boosts the Market Growth

The increase in number of the aged population requires novel interventions in the biological processes of aging people, that in return stimulate market growth. The latest report published by the United Nations states that the elderly population aged 65 and older is anticipated to double in number from 761 million in 2021 to approximately 1.6 billion in the year 2050. The increasing population of aged persons contributes to accelerating better ageing solutions, aiding healthy ageing, and subsequently enlarging market growth.

Rise in Prevalence of Age-Related Chronic Diseases Accelerates the Market Growth

The increase in spread of age-related chronic diseases increase the market growth trends to address the related causes of ageing. The latest report by Alzheimer's Disease International stated that the number of aged people suffering from dementia is anticipated to increase to around 78 million by 2030. This increases the demand for the development of medical therapies to target such biological processes of aging. This heightens engineering better ageing solutions aimed at alleviating the diseases and improving health and longevity.

Advancements in Regenerative Medicine Propels the Growth of the Market

The introduction of new medicine increases market growth by repairing and developing aged tissues or organs. For example, in April 2023, Mount Sinai's Institute introduce regenerative medicine focuses on treating age related or chronic conditions through advanced regenerative technologies. Such advanced technologies in regeneration medicine drives greater interests and investments in engineering better aging solutions to enhance longevity and quality of life.

Risk of Adverse Effects from Aging Treatments Hinders the Market Growth

The risk of effects from reverse aging treatments, such as gene editing and stem cell therapies increase the safety concerns that limit their adoption among people due to their side effects. This uncertainty leads to strict regulations and cautious use, thereby restraining the market challenges. 

Incorporation of Omics Data into Engineering Better Aging Diagnostic Tools Expected to Enhance the Market Expansion in Coming Years

The integration of omics data into engineering better aging diagnostic tools and medical devices is expected to create significant future opportunities by enabling highly personalized and precise interventions. 

Through analyzing genomics and metabolomics data into these tools helps to offer personalized treatments and early detection of age-related conditions, enhancing effectiveness and patient outcomes. This advancement is anticipated to drive innovation, slow ageing process and expand market growth opportunities in the forthcoming years. 

Market Segmentations and Scope of the Study

The engineering better ageing market report is segmented on the basis of product type, technology end users, and region. On the basis of product type, the market is divided into drugs, diagnostic tool, and medical devices. On the basis of technology, the market is classified into genomics, proteomics, epigenetics, gene therapy, regenerative medicine, and others. On the basis of end users, the market is segmented into healthcare, and research institutions. Healthcare is further divided into pharmaceutical companies, biotechnology companies, and specialized aging care center. Regional breakdown and analysis of each of the aforesaid segments include regions comprising North America, Europe, Asia-Pacific, and RoW.

Geographical Analysis

North America dominates the engineering better ageing market share and is projected to maintain its dominance throughout the forecast period. This is due to the increased disposable income that allows people of the region to spend money on advanced health and wellness technologies. The latest data from the Bureau of Economics shows that personal income in the U.S. increased from USD 50.4 billion, and disposable income grew by USD 37.7 billion in June 2024. Increased financial capacity of people around the region increases the demand for advanced ageing treatments aimed at improving their quality of life and life expectancy, thus fostering market growth.

Additionally, the surge in government investment in the region towards advanced medical technologies and regenerative medicine further propels the demand for engineering better aging solutions by fostering innovation and development in this field. 

The report published by the Government of Canada report 2024 states that Canadian government announced the opening of STEMCELL Technologies, an advanced medical facility supported by a USD 16.56 million investment from the federal government in 2023. This support enhances the availability of advanced treatments and boosts the market growth by creating an advanced infrastructure for developing and delivering advanced aging solutions. 

On the other hand, the Asia-Pacific region is expected to show a steady rise in the engineering better ageing market share. This is due to rise in the aging population in countries such as China, and Japan that increases the demand for advanced therapies and technologies that address age-related conditions and promote healthy aging. 

The latest report of the World Economic forum 2023 states that in Japan about 36.23 million individuals, being over 65 in 2023. This demographic shift propels investment in innovative solutions, creating a substantial market for engineering better aging solutions, ensuring slowing down of ageing process among the people. 

Furthermore, the increase in elderly chronic diseases, like heart disease and diabetes within the region, adds to the growth in the market by triggering the need for innovative therapies and technologies targeting the biological processes underlying these conditions. 

The current report by the American College of Cardiology says that India is faced with a heavy burden of noncommunicable diseases which amount to 65% total deaths in 2023 with nearly more than 25% related to heart diseases and risk factors like diabetes which drives the innovations towards developing such advanced therapies to prevent, manage or reverse aging effect and to boost the overall health as well as life expectancy therein enhancing market growth.

Competitive Landscape

Various key market players operating in the engineering better ageing industry includes Altos Labs, Inc., Unity Biotechnology, Inc., AgeX Therapeutics, Inc., Repair Biotechnologies, Inc., Mount Sinai Health System, Genflow Biosciences Plc, Christian Dior SE., and others. These market players are adopting various strategies such as research and developments to introduce innovative reverse ageing solutions and other diagnostic tools related to the market.

Key Benefits

• The report provides quantitative analysis and estimations of the engineering better ageing market from 2025 to 2030, which assists in identifying the prevailing market opportunities.

• The study comprises a deep dive analysis of the engineering better ageing market including the current and future trends to depict prevalent investment pockets in the industry.

• Information related to key drivers, restraints, and opportunities and their impact on the engineering better ageing market is provided in the report. 

• Competitive analysis of the players, along with their market share is provided in the report.

• SWOT analysis and Porters Five Forces model is elaborated on the study.

• Value chain analysis in the market study provides a clear picture of roles of stakeholders.

Engineering Better Ageing Market Key Segments

By Product Type

• Drugs

• Diagnostic Tool

• Medical Devices 

By Technology 

• Genomics

• Proteomics

• Epigenetics

• Gene Therapy

• Regenerative Medicine

• Others

By End Users

• Healthcare

• Pharmaceutical Companies

• Biotechnology Companies

• Specialized Aging Care Center

• Research Institutions 

By Region

• North America

  • The U.S.

  • Canada

  • Mexico

• Europe

  • The UK

  • Germany

  • France        

  • Italy        

  • Spain        

  • Denmark        

  • Netherlands        

  • Finland        

  • Sweden        

  • Norway        

  • Russia        

  • Rest of Europe    

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Indonesia

  • Singapore

  • Taiwan

  • Thailand

  • Rest of Asia Pacific

• RoW

  • Latin America

  • Middle East

  • Africa

Key Players

• Altos Labs, Inc.

• Unity Biotechnology, Inc.

• AgeX Therapeutics, Inc.

• Repair Biotechnologies, Inc.

• Mount Sinai Health System

• Genflow Biosciences Plc

• Christian Dior SE

REPORT SCOPE AND SEGMENTATION

Parameters	Details
Market Size in 2024	USD XXX Billion
Revenue Forecast in 2030	USD XXX Billion
Growth Rate	CAGR of XX% from 2025 to 2030
Analysis Period	2024–2030
Base Year Considered	2024
Forecast Period	2025–2030
Market Size Estimation	Billion (USD)
Growth Factors	Rise in geriatric population fuels the market. Increasing prevalence of age-related diseases boosts the market growth. Advancements in regenerative medicine propels the market growth
Countries Covered	28
Companies Profiled	7
Market Share	Available for 10 companies
Customization Scope	Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope.
Pricing and Purchase Options	Avail customized purchase options to meet your exact research needs.